financetom
Business
financetom
/
Business
/
Nano Nuclear Energy Submits 6 Patent Applications to USPTO for Zeus Microreactor
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nano Nuclear Energy Submits 6 Patent Applications to USPTO for Zeus Microreactor
May 30, 2025 6:32 AM

09:09 AM EDT, 05/30/2025 (MT Newswires) -- Nano Nuclear Energy ( NNE ) said Friday it has submitted six utility patent applications to the US Patent and Trademark Office, or USPTO, for its Zeus microreactor.

The company is developing Zeus as a solid-core battery reactor with a fully sealed core that utilizes a conductive moderator matrix to dispel fission heat, Nano Nuclear added.

Shares of the company were down more than 4% in recent Friday premarket activity.

Price: 29.75, Change: -1.39, Percent Change: -4.46

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Amazon.com's Zoox Automated Driving System Under US Traffic Safety Investigation
Amazon.com's Zoox Automated Driving System Under US Traffic Safety Investigation
May 13, 2024
07:55 AM EDT, 05/13/2024 (MT Newswires) -- Amazon.com's ( AMZN ) Zoox automated driving system is under preliminary investigation by the US National Highway Traffic Safety Administration over unexpected braking that led to two rear-end collisions, causing injuries to two motorcyclists, the agency said in a document Monday. Both incidents occurred during daytime lighting conditions and involved a Toyota Highlander...
Merck Halts Drug Combination Arm of Study Testing Potential Melanoma Treatment
Merck Halts Drug Combination Arm of Study Testing Potential Melanoma Treatment
May 13, 2024
07:58 AM EDT, 05/13/2024 (MT Newswires) -- Merc (MRK) said Monday it halted the vibostolimab and pembrolizumab combination arm of its phase 3 trial evaluating investigational adjuvant treatments for patients with resected high-risk melanoma. Data so far showed that the primary endpoint of recurrence-free survival met the pre-specified futility criteria. However, the drug company said that a higher rate of...
Bitfarms Accelerates Previously Announced CEO Termination, Reschedules Q1 Report to May 15
Bitfarms Accelerates Previously Announced CEO Termination, Reschedules Q1 Report to May 15
May 13, 2024
07:55 AM EDT, 05/13/2024 (MT Newswires) -- Bitfarms ( BITF ) on Monday said Geoffrey Morphy, who had been continuing as chief executive and president until a replacement was appointed, has been terminated effective immediately. Nicolas Bonta, Bitfarms' ( BITF ) chairman and co-founder, has been appointed interim CEO and president. On May 10, Morphy filed a statement of claim...
ESR says has investor group's proposal to take it private
ESR says has investor group's proposal to take it private
May 13, 2024
HONG KONG, May 13 (Reuters) - Hong Kong-listed real estate fund manager ESR Group ( ESRCF ), which halted trading in its shares on Monday, said in an exchange filing that a group of investors has proposed to take the company currently valued at $5.4 billion private. ESR, which is backed by U.S. private equity firm Warburg Pincus LLC, said...
Copyright 2023-2026 - www.financetom.com All Rights Reserved